Skip to main content

Susana Miravet Delgado

Institutions of which they are part

Postdoctoral researcher
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Susana Miravet Delgado

Institutions of which they are part

Postdoctoral researcher
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Projects

ESTUDIO Y DESARROLLO DE LA PRIMERA PLATAFORMA TECNOLÓGICA DE ENSAYOS PARA VIRUS ADENOASOCIADOS EN TERÁPIA GÉNICA

IP: Miguel Chillon Rodriguez
Collaborators: Susana Miravet Delgado, Laia Rubio Ortega, Marina Tarrés Mercader, ESTUDIO Y DESARROLLO DE LA PRIMERA PLATAFORMA TECNOLÓGICA DE ENSAYOS PARA VIRUS ADENOASOCIADOS EN TERÁPIA GÉNICA
Funding agency: Instituto de Salud Carlos III
Funding: 296571
Reference: PMPTA22/00048
Duration: 01/01/2023 - 30/06/2025

Related news

The treatment, licensed to Klotho Neurosciences, is based on a technology developed at the Universitat Autònoma de Barcelona (UAB) with the participation of VHIR.

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

This gene therapy protects mice against cognitive deficits associated with aging, improves motor function, and delays the onset of diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease.

Related professionals

Ariadna Garcia Rodriguez

Ariadna Garcia Rodriguez

Research technician
Childhood Cancer and Blood Disorders
Read more
Andrea Nieto I Brocal

Andrea Nieto I Brocal

Medium Grade Technician
Human Resources Directorate
Read more
Luís Gros Subias

Luís Gros Subias

Childhood Cancer and Blood Disorders
Read more
Angel Michael Ortiz Zúñiga

Angel Michael Ortiz Zúñiga

Predoctoral researcher
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.